Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Carolyn Paulson

6PUBLICATIONS

19CO-AUTHORS

Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Innate immunityGlycoconjugatesBiologically active moleculesStructural properties of condensed matter

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (6)

Sort by Publication Date:

|Jun 26, 2023

Zafirlukast Is a Promising Scaffold for Selectively Inhibiting TNFR1 Signaling.

Nagamani Vunnam, Mu Yang, Chih Hung Lo

|Mar 10, 2023

Discovery of a Non-competitive TNFR1 Antagonist Affibody with Picomolar Monovalent Potency That Does Not Affect TNFR2 Function.

Nagamani Vunnam, MaryJane Been, Evan Huber

|Sep 26, 2022

Broad Tricyclic Ring Inhibitors Block SARS-CoV-2 Spike Function Required for Viral Entry.

Sneha Ratnapriya, Anthony R Braun, Héctor Cervera Benet

|Aug 09, 2022

Fluorescence Lifetime Measurement of Prefibrillar Sickle Hemoglobin Oligomers as a Platform for Drug Discovery in Sickle Cell Disease.

Nagamani Vunnam, Scott Hansen, Dillon C Williams

|Apr 10, 2020

Function and Aggregation in Structural Eye Lens Crystallins.

Kyle W Roskamp, Carolyn N Paulson, William D Brubaker

|Oct 05, 2017

Structure-Activity Studies of N-Butyl-1-deoxynojirimycin (NB-DNJ) Analogues: Discovery of Potent and Selective Aminocyclopentitol Inhibitors of GBA1 and GBA2.

Xingxian Gu, Vijayalaxmi Gupta, Yan Yang

Pageof 1

Frequent Collaborators

4 joint publications

Jonathan N Sachs

2 joint publications

MaryJane Been

2 joint publications

Nagamani Vunnam

1 joint publications

Xingxian Gu

1 joint publications

Vijayalaxmi Gupta

1 joint publications

Yan Yang

1 joint publications

Jin-Yi Zhu

1 joint publications

Erick J Carlson

1 joint publications

Joseph S Tash

1 joint publications

David M Ferguson

Frequent Collaborators

4 joint publications

Jonathan N Sachs

2 joint publications

MaryJane Been

2 joint publications

Nagamani Vunnam

1 joint publications

Xingxian Gu

Top Related Videos

Myeloid Innate Signaling Pathway Regulation by MALT1 Paracaspase Activity

Myeloid Innate Signaling Pathway Regulation by MALT1 Paracaspase Activity

Published on : Jan 07, 2019

Determination of the Relative Potency of an Anti-TNF Monoclonal Antibody (mAb) by Neutralizing TNF Using an <em>In Vitro </em>Bioanalytical Method

Determination of the Relative Potency of an Anti-TNF Monoclonal Antibody (mAb) by Neutralizing TNF Using an <em>In Vitro </em>Bioanalytical Method

Published on : Sep 16, 2017

Production of Pseudotyped Particles to Study Highly Pathogenic Coronaviruses in a Biosafety Level 2 Setting

Production of Pseudotyped Particles to Study Highly Pathogenic Coronaviruses in a Biosafety Level 2 Setting

Published on : Mar 01, 2019

See more related videos

Top Related Videos

Myeloid Innate Signaling Pathway Regulation by MALT1 Paracaspase Activity

Myeloid Innate Signaling Pathway Regulation by MALT1 Paracaspase Activity

Published on : Jan 07, 2019

Determination of the Relative Potency of an Anti-TNF Monoclonal Antibody (mAb) by Neutralizing TNF Using an <em>In Vitro </em>Bioanalytical Method

Determination of the Relative Potency of an Anti-TNF Monoclonal Antibody (mAb) by Neutralizing TNF Using an <em>In Vitro </em>Bioanalytical Method

Published on : Sep 16, 2017

Production of Pseudotyped Particles to Study Highly Pathogenic Coronaviruses in a Biosafety Level 2 Setting

Production of Pseudotyped Particles to Study Highly Pathogenic Coronaviruses in a Biosafety Level 2 Setting

Published on : Mar 01, 2019

See more related videos